Inhibitory effects of antiparkinsonian drugs and caspase inhibitors in a parkinsonian flatworm model

J Pharmacol Sci. 2003 Jun;92(2):137-42. doi: 10.1254/jphs.92.137.

Abstract

It has been known that rotenone and 1-methyl-4-phenylpyridinium ion (MPP(+), a metabolite of MPTP), which inhibit mitochondrial complex I, are useful tools for parkinsonian models in vertebrates such as primates and rodents. Planarian, an invertebrate flatworm, has a high potential for regeneration, and dopamine plays a key role in its behavior. In the present study, we examined a cloned planarian, the GI strain from Dugesia japonica. Planarians that were treated with rotenone or MPTP underwent autolysis and individual death in a concentration- and time-dependent manner. In addition, these effects induced by rotenone or MPTP were inhibited by several antiparkinsonian drugs and caspase inhibitors. These results suggest that the degeneration of planarian dopaminergic system induced by rotenone or MPTP may be mediated through caspase-like activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiparkinson Agents / pharmacology
  • Antiparkinson Agents / therapeutic use*
  • Caspase Inhibitors
  • Caspases / metabolism
  • Disease Models, Animal*
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use*
  • Parkinsonian Disorders / drug therapy*
  • Parkinsonian Disorders / enzymology
  • Planarians / drug effects
  • Planarians / enzymology
  • Platyhelminths / drug effects*
  • Platyhelminths / enzymology

Substances

  • Antiparkinson Agents
  • Caspase Inhibitors
  • Enzyme Inhibitors
  • Caspases